FUSION PHARMACEUTICALS INC (FUSN)
CA36118A1003 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -104.28M | -94.90M | -87.61M | -81.05M | -78.33M | |||
| Depreciation Amortization | 1.44M | 1.34M | 910.00K | 630.00K | 480.00K | |||
| Income Taxes - Deferred | 930.00K | 845.00K | -3.16M | -990.00K | -580.00K | |||
| Change In Working Capital | 4.53M | -1.32M | 3.66M | -14.60M | 5.74M | |||
| Interest Paid | 5.15M | 4.62M | 1.59M | N/A | N/A | |||
| Taxes Paid | N/A | 1.67M | 1.40M | 3.96M | 500.00K | |||
| Other non cash items | 13.70M | 12.22M | 12.93M | 20.26M | 42.92M | |||
| OPERATING CASH FLOW | -83.67M | -81.80M | -73.28M | -75.74M | -29.77M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.00M | -3.89M | -2.14M | -1.49M | -1.12M | |||
| Other Investing Activity | -84.60M | -38.87M | 25.23M | 39.27M | -209.33M | |||
| INVESTING CASH FLOW | -88.60M | -42.76M | 23.09M | 37.77M | -210.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 34.69M | N/A | N/A | |||
| Stock Issued/Repurchased | 131.76M | 146.04M | 6.04M | 620.00K | 270.08M | |||
| Other Financing Activity | -171.00K | -4.03M | 0.00 | -280.00K | -4.57M | |||
| FINANCING CASH FLOW | 146.50M | 142.01M | 40.73M | 350.00K | 265.51M | |||
| CHANGE IN CASH | -25.77M | 17.44M | -9.46M | -37.62M | 25.29M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -83.67M | -81.80M | -73.28M | -75.74M | -29.77M | |||
| Capital Expenditure | -4.00M | -3.89M | -2.14M | -1.49M | -1.12M | |||
| FREE CASH FLOW | -87.67M | -85.69M | -75.42M | -77.23M | -30.89M | |||
All data in USD